论文部分内容阅读
慢性丙型肝炎(hepatitis c,CHC)是导致肝硬化、肝癌等晚期肝病的主要原因之一。丙型肝炎患者只要符合抗病毒的适应证,就应进行积极正确的抗病毒治疗。丙型肝炎患者抗病毒治疗国际上公认的标准方案为聚乙二醇干扰素(pegylated-interferon,PEG-IFN)与利巴韦林(RBV)的联合
Chronic hepatitis C (CHC) is one of the major causes of advanced liver disease such as cirrhosis and liver cancer. Patients with hepatitis C who meet the anti-virus indications should be positive and correct antiviral treatment. An internationally accepted standard protocol for antiviral therapy in patients with hepatitis C is the combination of pegylated-interferon (PEG-IFN) and ribavirin (RBV)